Decrease in uptake of SARS-CoV-2 vaccine in patients with inflammatory bowel disease on intravenous biological therapy.

Selim, Rania; Wellens, Judith; Brann, Stephanie; Marlow, Luke; Adams, Alex; Satsangi, Jack J

Selim, Rania; Wellens, Judith; Brann, Stephanie; Marlow, Luke; Adams, Alex; Satsangi, Jack J.

Selim R; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK; Faculty of Medicine, Imperial College London, London, UK.
Wellens J; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK; Translational Research for Gastrointestinal Diseases, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium. Electronic address: Judith.wellens@kuleuven.be.
Brann S; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Marlow L; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Adams A; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Satsangi JJ; Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, OX3 9DU, UK.

Lancet Gastroenterol Hepatol ; 7(11): 984-985, 2022 11.

Article in English | MEDLINE | ID: covidwho-2042289

Subject(s)

COVID-19; Inflammatory Bowel Diseases; Biological Therapy; COVID-19/prevention & control; COVID-19 Vaccines; Chronic Disease; Humans; Inflammatory Bowel Diseases/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Inflammatory Bowel Diseases / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Lancet Gastroenterol Hepatol Year: 2022 Document Type: Article Affiliation country: S2468-1253(22)00302-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google